Epidemiology — MCQs

In a developing country, the prevalence of diabetes mellitus is increasing at an annual rate of 1.8%. Using epidemiological principles similar to the Rule of 70, approximately how many years will it take for the diabetes prevalence to double, and what are the primary healthcare planning implications of this growth rate?

Q1776

Which of the following conditions does not primarily benefit from secondary level prevention?

Q1777

Which of the following viral diseases is least commonly reported in India?

Q1778

Most common mode of transmission of nosocomial infection is -

Q1779

Spot map is used for?

Q1780

In the context of disease screening, which type of lead time is most beneficial for effective screening?

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1771: What is a limitation of the case fatality rate?

A. Not useful in acute infectious disease
B. Not related to virulence
C. Time period not specified (Correct Answer)
D. It is not related to survival rate

Explanation: ***Time period not specified*** - The **case fatality rate (CFR)** is sometimes presented without a clear time frame, making it difficult to compare across different studies or diseases. - A CFR calculated over **24 hours** is vastly different from one calculated over **30 days** or **one year**, yet both could be presented simply as "CFR" *Not useful in acute infectious disease* - The CFR is highly **useful** in acute infectious diseases, as it directly measures the **severity** and immediate impact of an outbreak. - It helps public health officials understand the **lethality** of an infectious agent and aids in resource allocation and intervention strategies. *Not related to virulence* - **Case fatality rate** is directly related to **virulence**, as it reflects the proportion of affected individuals who die from the disease. - A higher CFR indicates a more **virulent pathogen** or a more severe disease process. *It is not related to survival rate* - The **case fatality rate** is inherently linked to the **survival rate**; they are complementary measures. - If the CFR is X%, then the associated survival rate is (100 - X)%, representing the proportion of cases that do not die from the disease.

Question 1772: In the context of demographic studies, how is 'population explosion' defined in terms of growth rate?

A. > 2% (Correct Answer)
B. 0.5% - 1.0%
C. 1.5% - 2.0%
D. 1.0% - 1.5%

Explanation: ***> 2%*** - A **population explosion** is generally defined as a rapid and significant increase in population size, typically characterized by an annual growth rate exceeding **2%**. - This rate indicates a **doubling time** of approximately 35 years or less, leading to substantial demographic changes. - In the context of Indian demographics, this definition is particularly relevant to the period of rapid population growth experienced in the mid-20th century. *0.5% - 1.0%* - A growth rate in this range is considered **moderate** or even **low** for many developing countries and would not be indicative of a "population explosion." - This rate represents a relatively **stable** or slowly increasing population, not the rapid surge implied by the term. *1.5% - 2.0%* - While a 1.5% to 2.0% growth rate is significant, it often falls short of the threshold typically associated with a "population explosion," which implies a more **accelerated** and **unsustainable** rate of increase. - Many countries with this growth rate face challenges, but it's generally not classified as an "explosion" unless other contextual factors are extreme. *1.0% - 1.5%* - A growth rate between 1.0% and 1.5% is considered a **moderate** rate of population increase. - This range does not signify the rapid and often unmanageable growth implied by the term **population explosion**.

Question 1773: Which of the following diseases is not covered under the Integrated Disease Surveillance Project (IDSP)?

A. Tuberculosis
B. Cholera
C. Herpes zoster (Correct Answer)
D. Meningococcal disease

Explanation: ***Herpes zoster*** - **Herpes zoster** (shingles) is not included in the Integrated Disease Surveillance Project (IDSP) as it is neither an epidemic-prone disease nor a notifiable disease under the program. - IDSP focuses on diseases with significant public health impact, epidemic potential, or those requiring immediate public health response. - While herpes zoster can cause morbidity in immunocompromised individuals, it does not pose a widespread public health threat requiring national surveillance. *Tuberculosis* - **Tuberculosis (TB)** is explicitly covered under IDSP as a major notifiable disease due to its high burden in India and significant public health importance. - TB surveillance under IDSP helps monitor disease trends, detect outbreaks, and evaluate the effectiveness of the National Tuberculosis Elimination Programme. - Regular reporting and surveillance are essential for achieving TB elimination goals. *Cholera* - **Cholera** is a priority disease under IDSP as an epidemic-prone disease with potential for rapid outbreaks and high mortality if untreated. - It is part of the core surveillance list due to its ability to cause severe dehydration and waterborne epidemics. - Early detection through IDSP enables timely implementation of control measures including safe water supply and oral rehydration therapy. *Meningococcal disease* - **Meningococcal disease** (acute bacterial meningitis) is covered under IDSP due to its high case fatality rate, epidemic potential, and need for urgent public health response. - Surveillance is critical for early outbreak detection and implementation of preventive measures such as mass vaccination and chemoprophylaxis. - Close monitoring helps identify circulating serotypes and guide vaccination strategies.

Question 1774: Which of the following is NOT a criterion for defining a polio epidemic?

A. Caused by same virus type
B. Cases should occur in same locality
C. 2 or more cases
D. Cases occurring during a 6 month period (Correct Answer)

Explanation: ***Correct: Cases occurring during a 6 month period*** - The definition of a polio epidemic primarily focuses on criteria like the number of cases, their geographical proximity, and the viral serotype causing the infection, not a specific duration of time over which cases occur. - While an outbreak naturally unfolds over a period, a fixed 6-month window is **not a formal defining criterion** for an epidemic, which typically emphasizes a sudden, significant increase above expected levels. *Incorrect: 2 or more cases* - An epidemic is generally defined by an **unusual increase in disease incidence**, and even two confirmed cases, especially in areas with low endemicity or where polio is eradicated, can signal an outbreak. - The presence of **two or more paralytic polio cases** within a specific area is often considered a critical threshold for declaring an epidemic, particularly for **wild poliovirus**. *Incorrect: Cases should occur in same locality* - For an epidemic to be declared, the cases must be **geographically linked** to indicate a common source or local transmission. - Cases spread across different, unconnected regions would suggest **sporadic occurrences** rather than a localized epidemic. *Incorrect: Caused by same virus type* - An epidemic implies a **common etiologic agent**, meaning the cases should be linked to the same serotype of **poliovirus** (e.g., wild poliovirus type 1). - If cases are caused by different serotypes, it indicates **multiple independent introductions** rather than a single epidemic outbreak.

Question 1775: In a developing country, the prevalence of diabetes mellitus is increasing at an annual rate of 1.8%. Using epidemiological principles similar to the Rule of 70, approximately how many years will it take for the diabetes prevalence to double, and what are the primary healthcare planning implications of this growth rate?

A. 30-35 years
B. 35-46 years (Correct Answer)
C. 25-30 years
D. 20-25 years

Explanation: ***35-46 years*** - Using the **Rule of 70**, divide 70 by the annual growth rate (1.8%): 70 / 1.8 ≈ **38.89 years**. This value falls within the 35-46 year range. - The doubling of diabetes prevalence within this timeframe necessitates significant **healthcare planning implications**, including increased demand for diagnostic services, medications, and specialized care, as well as focused preventative measures. *30-35 years* - This range is too low, as the calculated doubling time of approximately **38.89 years** is longer than this range. While close, this timeframe underestimates the actual time needed for prevalence to double. *25-30 years* - This range is significantly lower than the calculated doubling time of approximately **38.89 years**, meaning it underestimates the time required for diabetes prevalence to double by about 9-14 years. *20-25 years* - This range is far too low, as the calculated doubling time of approximately **38.89 years** is much longer. This timeframe would suggest a much higher annual growth rate than the stated 1.8%.

Question 1776: Which of the following conditions does not primarily benefit from secondary level prevention?

A. Coronary heart disease
B. Leprosy
C. TB
D. None of the options (Correct Answer)

Explanation: ***None of the options*** - This is the **correct answer** because all three conditions listed (Coronary heart disease, TB, and Leprosy) DO significantly benefit from **secondary prevention** strategies. - The question uses negation ("does not"), asking which condition does NOT benefit from secondary prevention. - Since all three diseases benefit from secondary prevention, the answer is "None of the options." **Why each condition DOES benefit from secondary prevention:** *Coronary Heart Disease (CHD)* - **Secondary prevention** includes screening for risk factors (hypertension, hyperlipidemia, diabetes), early detection through ECG and cardiac biomarkers, and prompt intervention. - Post-event management with antiplatelets, statins, beta-blockers, and lifestyle modifications prevents recurrence and reduces mortality. - Early detection and treatment of risk factors halt disease progression and prevent complications. *Tuberculosis (TB)* - **Secondary prevention** is crucial through **early case detection** (contact tracing, active case finding, screening high-risk populations) and **prompt initiation of antitubercular therapy**. - Early diagnosis via sputum microscopy, GeneXpert, and chest X-ray prevents disease progression, reduces transmission, and prevents complications like miliary TB or TB meningitis. - Timely treatment ensures cure and prevents development of drug resistance. *Leprosy* - **Secondary prevention** involves **active case detection through surveys** and **prompt multi-drug therapy (MDT)**. - Early diagnosis and treatment prevent irreversible nerve damage, deformities, and disabilities. - Reduces transmission in the community and prevents progression to advanced stages.

Question 1777: Which of the following viral diseases is least commonly reported in India?

A. Japanese B encephalitis
B. Lassa fever (Correct Answer)
C. KFD
D. Dengue

Explanation: ***Lassa fever*** - **Lassa fever** is endemic to West Africa, with the **multimammate rat** being its primary reservoir. - Cases of Lassa fever are **extremely rare** in India, primarily limited to travel-related instances due to the geographical distribution of the disease and its vector. *Japanese B encephalitis* - **Japanese B encephalitis (JBE)** is a significant public health concern in India, particularly in endemic regions. - It is a mosquito-borne viral disease, and **vaccination programs** are ongoing to control its spread. *KFD* - **Kyasanur Forest Disease (KFD)** is an endemic viral hemorrhagic fever primarily found in the **Karnataka state of India**. - It is transmitted by **ticks**, making it a regionally significant but recognized viral disease within India. *Dengue* - **Dengue** is one of the most commonly reported and widespread viral diseases in India. - It is a **mosquito-borne** illness with frequent outbreaks occurring across various parts of the country.

Question 1778: Most common mode of transmission of nosocomial infection is -

A. Hand contact (Correct Answer)
B. Droplet infection
C. Blood and blood products
D. Contaminated water

Explanation: ***Hand contact*** - **Direct contact** with healthcare workers' contaminated hands is the primary way pathogens are transferred between patients in a healthcare setting. - Failure to perform adequate **hand hygiene** between patient contacts is the single most important factor contributing to nosocomial infection transmission. *Droplet infection* - While droplet transmission can cause nosocomial infections, especially for respiratory viruses, it is not the most common mode of transmission for the overall burden of healthcare-associated infections. - **Droplets** usually travel short distances and deposit on mucous membranes of the nose, mouth, or eyes of a susceptible host. *Blood and blood products* - Transmission through **blood and blood products** is a significant concern for specific infections (e.g., HIV, hepatitis B/C), but the incidence is relatively low due to stringent screening and safety protocols. - This mode accounts for a small fraction of overall nosocomial infections compared to contact transmission. *Contaminated water* - **Contaminated water** can lead to outbreaks (e.g., *Legionella*, *Pseudomonas*), especially in immunocompromised patients, but it is not the most frequent mode of transmission on a day-to-day basis across all types of nosocomial infections. - Healthcare facilities implement measures to ensure water safety, limiting this as the primary route.

Question 1779: Spot map is used for?

A. Local distribution of disease (Correct Answer)
B. Rural-urban variation
C. National variation
D. None of the options

Explanation: ***Local distribution of disease*** - A **spot map** visually represents the geographic distribution of individual cases of a disease or health event. - Each 'spot' on the map corresponds to the exact location where a case occurred, making it ideal for identifying **clusters** or patterns of disease within a specific area. *Rural-urban variation* - While a spot map could potentially show cases in both rural and urban settings, its primary purpose is not to specifically highlight the differences between these two broad categories. - Other types of **thematic maps** or **statistical analyses** are better suited for assessing rural-urban variations. *National variation* - A spot map would be impractical for showing national variation in detail, as it would require plotting individual cases across an entire country, leading to an overly cluttered and uninterpretable image. - **Choropleth maps**, which use shading or colors to represent data for predefined geographic areas (like states or provinces), are more appropriate for illustrating national trends or variations. *None of the options* - This option is incorrect because the primary use of a spot map aligns directly with illustrating the **local distribution of disease**.

Question 1780: In the context of disease screening, which type of lead time is most beneficial for effective screening?

A. Short lead time
B. Both short and long lead times are beneficial
C. Long lead time is beneficial for screening (Correct Answer)
D. Lead time has no impact on screening effectiveness

Explanation: ***Long lead time is beneficial for screening*** - **Long lead time** provides a greater window of opportunity between disease detection by screening and clinical symptom onset - This extended asymptomatic detectable phase allows for **early intervention** when treatments are most effective - Longer lead time correlates with improved prognosis and potential prevention of severe outcomes - Essential criterion for effective screening programs per **Wilson-Jungner criteria** *Short lead time* - Limited time between disease detectability and clinical symptoms - Reduces screening effectiveness as disease progresses rapidly - Minimal opportunity for beneficial early intervention *Both short and long lead times are beneficial* - Only **long lead time** is beneficial for screening programs - Short lead time actually limits screening effectiveness - Screening benefit is directly proportional to duration of asymptomatic detectable phase *Lead time has no impact on screening effectiveness* - **Lead time is crucial** for determining screening program effectiveness - Directly impacts the window for early detection and intervention - Without adequate lead time, screening loses its preventive value

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free